Results 301 to 310 of about 5,108,464 (344)
Some of the next articles are maybe not open access.
Surgical Clinics of North America, 2008
Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007.
Nishan, Chobanian, Charles S, Dietrich
openaire +2 more sources
Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007.
Nishan, Chobanian, Charles S, Dietrich
openaire +2 more sources
British Journal of Cancer, 1993
Mice have been used in ovarian cancer research mainly as hosts for cell lines derived from human ovarian tumors and ascites. Such models provided valuable information into the nature of metastatic ovarian cancer and possible treatment strategies. However,
S. Orsulic
semanticscholar +1 more source
Mice have been used in ovarian cancer research mainly as hosts for cell lines derived from human ovarian tumors and ascites. Such models provided valuable information into the nature of metastatic ovarian cancer and possible treatment strategies. However,
S. Orsulic
semanticscholar +1 more source
Seminars in Oncology Nursing, 1990
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival.
J H, Eriksson, J R, Walczak
openaire +2 more sources
The epidemiology of ovarian cancer [PDF]
International Journal of Gynecological Cancer, 2001 The overall mortality from epithelial ovarian cancer has changed little over the past 20 years. Despite the widely heralded introduction of new chemotherapy agents such as the taxanes and increased interest in the possibility of screening for early-stage disease the overall 5-year survival rate remains static at about 30%.
Edmondson, R J, Monaghan, J M
openaire +3 more sources
Radiologic Clinics of North America, 2007
Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient.
Svetlana, Mironov +3 more
openaire +2 more sources
Imaging has become an essential part of the clinical management of patients with ovarian cancer, contributing to tumor detection, characterization, staging, treatment planning, and follow-up. Imaging findings incorporated into the clinical impression assist in creating a treatment plan specific for an individual patient.
Svetlana, Mironov +3 more
openaire +2 more sources
Obstetrics & Gynecology, 2001
To examine the symptoms of ovarian cancer in patients compared with symptoms experienced by healthy women using a case-control design.Cases (n = 168) were women with ovarian cancer diagnosed at two hospitals in New York between 1994 and 1997 who were interviewed shortly after diagnosis.
Sara H. Olson +5 more
openaire +3 more sources
To examine the symptoms of ovarian cancer in patients compared with symptoms experienced by healthy women using a case-control design.Cases (n = 168) were women with ovarian cancer diagnosed at two hospitals in New York between 1994 and 1997 who were interviewed shortly after diagnosis.
Sara H. Olson +5 more
openaire +3 more sources
Clinical and translational advances in ovarian cancer therapy
Nature Cancer, 2023P. Konstantinopoulos, U. Matulonis
semanticscholar +1 more source
Tumor‐associated macrophage‐targeted therapeutics in ovarian cancer
International Journal of Cancer, 2020Ovarian cancer is one of the most common gynecological malignancies. The tumor microenvironment plays an important role in regulating the progression of ovarian cancer.
Yuanyuan An, Qing Yang
semanticscholar +1 more source
Ovarian Cysts and Ovarian Cancer
InnovAiT: Education and inspiration for general practice, 2009Ovarian cysts and tumours are a relatively common finding among women of many ages, particularly with the wider use of regular physical examinations and ultrasound. Although the finding of an ovarian mass can be a source of considerable anxiety, most of those in younger women are not malignant and may be able to be managed entirely within primary care.
Shiner, Alice, Burbos, Nikolaos
openaire +3 more sources
Journal of Reproductive Immunology, 1998
Previous observations from our laboratory have demonstrated that the levels of immunoreactive inhibin (ir-inh) are elevated in almost all patients with granulosa cell tumors and in the majority of postmenopausal women with mucinous ovarian cancers.
David Robertson +13 more
openaire +4 more sources
Previous observations from our laboratory have demonstrated that the levels of immunoreactive inhibin (ir-inh) are elevated in almost all patients with granulosa cell tumors and in the majority of postmenopausal women with mucinous ovarian cancers.
David Robertson +13 more
openaire +4 more sources